What is the target blood pressure for a patient with a solitary kidney and normal renal function, indicated by a creatinine level in the normal range, and current blood pressure of 128/90 mmHg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Pressure Management in a Patient with Solitary Kidney and Normal Renal Function

For a patient with a solitary kidney and normal renal function (creatinine in the 70s), the target blood pressure should be <140/90 mmHg, with consideration for a more stringent target of <130/80 mmHg if the patient can tolerate it without adverse effects. 1

Rationale for Blood Pressure Target

Current Guideline Recommendations

  • Different guidelines provide varying recommendations for blood pressure targets in patients with kidney disease:
    • The American College of Cardiology recommends <130/80 mmHg 1
    • European Society of Cardiology/European Society of Hypertension recommends systolic BP of 130-139 mmHg 2
    • National Institute for Health and Care Excellence (NICE) recommends <140/90 mmHg for CKD with low albuminuria 1
    • KDIGO (2021) recommends systolic BP <120 mmHg, though this is considered an outlier among guidelines 2

Special Considerations for Solitary Kidney

  • Patients with a solitary kidney require careful blood pressure management to preserve remaining kidney function
  • The current blood pressure of 128/90 mmHg (and home readings in the 120s/high 80s) indicates the diastolic pressure is above optimal targets
  • With normal renal function, the primary goal is to prevent progression of kidney disease while minimizing cardiovascular risk

Management Approach

Step 1: Initial Target

  • Begin with a target of <140/90 mmHg as a minimum goal 2
  • Focus particularly on reducing the diastolic pressure from the current 90 mmHg to <90 mmHg
  • Once this is achieved, consider further reduction to <130/80 mmHg if tolerated 1

Step 2: Medication Selection

  • First-line therapy should include an ACE inhibitor or ARB, which provides renoprotection 1
  • Add a thiazide-type diuretic if needed for additional BP control 2
  • If target BP is not achieved with two medications, consider adding a calcium channel blocker as a third agent

Step 3: Monitoring

  • Monitor kidney function and electrolytes 1-2 weeks after initiating or adjusting RAAS blockers 1
  • Check for orthostatic changes in blood pressure, especially if pursuing more intensive targets
  • Assess for symptoms of hypotension if pursuing lower targets
  • Monitor for any increase in creatinine (should not exceed 30% from baseline) 1

Important Caveats

Avoiding Overly Aggressive Targets

  • While KDIGO recommends a target of <120 mmHg systolic, this recommendation is based primarily on the SPRINT trial and may not be appropriate for all patients with kidney disease 2
  • Overly aggressive BP lowering could potentially lead to:
    • Acute kidney injury
    • Electrolyte abnormalities
    • Hypotension, especially in elderly patients 1
    • Excessive lowering of diastolic pressure (should generally not be <70 mmHg) 1

Monitoring Home Blood Pressure

  • Since the patient already monitors home blood pressure, encourage continued monitoring
  • Home readings in the 120s/high 80s suggest that office readings may be slightly elevated (white coat effect)
  • Target home readings of approximately 120-130/70-80 mmHg

Conclusion

For this patient with a solitary kidney, normal renal function, and current BP of 128/90 mmHg, the primary focus should be on reducing the diastolic pressure to <90 mmHg while maintaining the systolic pressure <140 mmHg. A more intensive target of <130/80 mmHg may be appropriate if well-tolerated, but pursuing targets below this level should be approached with caution to avoid adverse effects that could compromise the remaining kidney function.

References

Guideline

Blood Pressure Management in Chronic Kidney Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the best management approach for a patient with a horseshoe kidney and chronic hypertension?
What is the target blood pressure for a patient with stage 5 Chronic Kidney Disease (CKD) experiencing a hypertensive emergency?
What is the best course of action for a patient with uncontrolled hypertension (blood pressure 140/90), impaired glucose control (A1c 6.5), and impaired renal function (albumin/creatinine ratio 65) currently on Diovan (valsartan) 320mg and Metoprolol Succinate XL (metoprolol succinate) 25mg?
What is the recommended management for patients with Chronic Kidney Disease (CKD) stage 3 in a clinical setting?
What changes should be made to an African American male patient's current medication regimen, which includes Amlodipine (Amlodipine Besylate) 10mg daily and Carvedilol (Carvedilol) 12.5mg twice daily, to better control his elevated Systolic Blood Pressure (SBP) in the context of Chronic Kidney Disease (CKD) with a baseline creatinine level of 2.9?
What is the initial workup and treatment for a patient with thrombocytopenia (low platelet count)?
What is the management approach for a patient with significantly elevated BNP (Brain Natriuretic Peptide) levels?
What is the treatment for a left lower lobe small infiltrate?
Should I start this patient on a statin given their elevated lipid levels?
What is the management plan for a patient with mild elevation of left ventricular end diastolic pressure, preserved left ventricular systolic ejection, no significant coronary artery disease, and endothelial dysfunction?
What is the initial treatment approach for patients with scleroderma?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.